Life sciences-focused venture capital firm Epidarex Capital has picked up more than $145m of commitments at the first close of its fourth flagship fund, putting it above the predecessor vehicle it raised in 2020.
The post Life science VC investor Epidarex outdoes Fund III size at first close of Fund IV, pulls in $145m to date appeared first on AltAssets Private Equity News.
|
